相关实验视频
Updated: Sep 15, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
重新利用旧药物释放天生的免疫力
Fanchao Meng1, Hangxiang Wang2
1NHC Key Laboratory of Combined Multi-Organ Transplantation, Institute of Organ Transplantation of Zhejiang University, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Province, Hangzhou, 310003, China.
研究人员重新设计了一种现有的药物,以激活干扰素基因刺激器 (STING) 途径,增强对瘤的免疫反应. 这种新的方法通过一种独特的机制促进了STING信号传递和免疫激活,与典型的STING激动剂不同.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 干扰素基因刺激 (STING) 途径对天生的免疫非常重要.
- 激活STING可以增强抗瘤免疫反应和瘤免疫性.
- 传统的STING激动剂存在,但可能有局限性.
研究的目的:
- 探索用于激活STING通路的替代方法.
- 识别可用于STING激活的现有药物.
- 研究一种新的STING信号传递和免疫激活机制.
主要方法:
- 对临床批准的药物进行查,以检测STING通路调节活性.
- 重用药对STING信号传递的作用机制的描述.
- 在相关模型中评估免疫激活和抗瘤效应.
主要成果:
- 一种经过临床批准的药物被确定为一种新的STING激活剂.
- 这种重新设计的药物可以促进STING信号传递和免疫激活.
- 药物的作用方式与传统的STING激动剂不同.
结论:
- 重用现有药物为新型STING通路激活提供了一个有希望的策略.
- 这种方法通过增强免疫反应,为癌症免疫治疗提供了一个新的途径.
- 独特的作用机制可以克服当前STING激动剂的局限性.
更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Microorganisms in Medicine and Therapeutics
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Transduction
Prodrugs
Prodrugs help overcome...